Research groups
-
Barca Group
Our research combines quantum chemistry, AI, and high-performance computing to create predictive models and simulations that rival traditional experiments.
-
Capuano Group
Our group specialises in the design, synthesis and biological evaluation of ligands targeting proteins implicated in mental health disorders and cancer.
-
Norton & Wai Group
Our group uses biophysical approaches, molecular modelling and design to develop peptides, including those from venomous organisms, as therapeutic candidates.
-
Priebbenow Group
We discover new modes of chemical reactivity to develop chemical reactions for the synthesis and manufacture of pharmaceutically relevant molecules.
-
Shi Group
Our group investigates protein-small molecule interactions for fragment-based ligand discovery and structure-based drug design.
-
Smedley Group
Our research focuses on the development of innovative synthetic strategies for the selective assembly of molecular scaffolds commonly found in bioactive molecules.
